A B S T R A C T f(-Adrenergic receptors on human mononuclear leukocytes were assessed using ['251]iodohydroxybenzylpindolol binding. Subjects were studied supine and after being ambulatory, a maneuver that increases plasma catecholamines approximately twofold. (3-Receptor affinity for agonists, measured by the competition of ['25I]iodohydroxybenzylpindolol binding by (-)isoproterenol was significantly reduced with ambulation and this reduction was associated with a reduction in the proportion of (3-receptors binding agonist with a high affinity from a mean (±SEM) of 42±5 to 24±2% (P < 0.01). In a parallel series, ,B-adrenergic-stimulated adenylate cyclase activity was also reduced with postural change from 4.6±1.1 to 2.4±0.6 pmol [32P]cAMP/min per mg protein (P < 0.05) after ambulation. Similar reductions in the proportion of receptors binding agonist with a high affinity were seen after infusion of norepinephrine. We conclude that the maneuver of ambulation reduces leukocyte ,B-receptor responsiveness and affinity for agonists, probably by the effect of increased plasma catecholamines mediating an uncoupling of the (3-receptor-adenylate cyclase complex.
INTRODUCTION
(3-Adrenergic receptor-mediated function is attenuated by persistent exposure to catecholamines (1) (2) (3) (4) (5) (6) (7) (8) (9) This process has been referred to as tachyphylaxis, or desensitization (3) , and has been correlated with decreased (3-receptor mediated cyclic AMP (cAMP)' production (1) (2) (3) (4) (5) (6) (7) (8) (9) and, in some circumstances, with (3-receptor loss (6) (7) (8) (9) . This loss in (3-receptor density has been demonstrated in vitro (6) (7) (8) (9) , as well as in man (10) (11) (12) (13) (14) (15) . In man, leukocytes have been used to monitor (3-receptor properties ex vivo, since it has been suggested that changes in leukocyte (3-receptors may reflect alterations in (3-receptors on less accessible tissues (e.g., heart, lung) (10, 12, 13, 16) .
Recently, it has been appreciated that important changes in (3-receptor function may occur before the apparent loss of (3-receptors from target cells. Harden et al. (17) demonstrated that short-term (15 min) incubation of astrocytoma cells with agonist resulted in a rapid reduction in (3-adrenergic-stimulated adenylate cyclase activity that paralleled a reduction in receptor affinity for agonists, but was not correlated with a reduction in receptor density. Krall et al. (18) incubated human leukocytes with 0.01 nM isoproterenol, a concentration of agonist that would occupy only a very small fraction of the total (3-receptor population, and found that the ability of isoproterenol to elevate cAMP levels was impaired without any change in receptor density. Similarly, these investigators observed that infusion of isoproterenol into humans promoted a loss in (3-adrenergic-mediated cAMP accumulation in leukocytes, with no change in leukocyte (3-receptor density. These data suggest that loss of ,B-adrenergic responsiveness without change in p3-receptor density might occur in vivo at low levels of ,8-agonists comparable to the concentrations of circulating catecholamines occurring physiologically.
Loss of responsiveness (desensitization) without reduction in receptor density suggests a functional uncoupling of the j3-receptor-adenylate cyclase system. Characterization of the molecular components of this system and how they interact has allowed greater insights into the possible molecular mechanisms involved in receptor-cyclase coupling. The multicomponent ,B-receptor-adenylate cyclase system is composed of a catalytic subunit responsible for synthesis of cAMP, the receptor that binds agonists and a guanine nucleotide-binding regulatory protein (G) that couples receptor occupancy to the stimulation of catalytic activity (19, 20) . Analysis of radioligand binding to the ,-receptor has characterized the formation of a highaffinity complex between the (3-receptor (R) and ,B-adrenergic agonists (H) (21) . The high-affinity state has been identified as the ternary complex of agonist-receptor-G (H-R-G) (22) . Guanine nucleotides, via binding to G, mediate the dissociation of the presumed agonist-fl-receptor-G complex and the conversion to the low-affinity state of the receptor for agonists (agonist-receptor complex H-R) (23) . Since formation of the high-affinity complex, agonist-receptor-G (H-R-G), appears to be required for agonist activation of adenylate cyclase, alterations in the ability to form highaffinity complexes could account for the observed changes that accompany desensitization. In fact, in vitro studies of desensitization of the (3-receptor adenylate cyclase complex in animal model systems have demonstrated a reduction in the number of high-affinity receptor agonist complexes that can be detected subsequent to chronic catecholamine exposure (23) .
To test the hypothesis that functional uncoupling of the adenylate cyclase system might occur in man, we investigated the effect of acute elevations in plasma catecholamines on the human leukocyte ,B-receptor and coupled adenylate cyclase system. To raise endogenous catecholamines within the levels that occur physiologically, we used the maneuver of upright posture, which has previously been shown to evoke an acute rise in plasma epinephrine and norepinephrine levels (24) . Lymphocytes were isolated from fresh citrated blood according to the method of Boyum (25) . Whole blood was centrifuged at 300 g for 14 min. The platelet-rich plasma was aspirated and the buffy coat collected and diluted with phosphate-buffered saline (pH 7.4) . A Ficoll/Hypaque (6%/ 10%) solution was carefully subfused and the samples centrifuged at 400 g for 40 min. After careful removal of the plasma/saline layer, the lymphocyte band (consisting of at least 85% small lymphocytes) was harvested by aspiration and a mononuclear broken cell lysate prepared according to a modification of the methods of Aarons et al. (26) . The lymphocyte band was resuspended in 30 ml 0.9% NaCl with 12.5 mM MgCl2, 1.5 mM EDTA buffered with 20 mM Tris-HCI (pH 7.4 at 37°C), and centrifuged for 10 min at 40,000 g at 4°C. The pellet was resuspended in ice-cold deionized water, homogenized for 5 s (Brinkmann Polytron, setting 5; Brinkmann Instruments, Inc., Westbury, NY), and centrifuged at 40,000 g for 10 min at 4°C. The pellet was resuspended in 20 ml of 0.9% NaCl with 20 mM Tris, 12.5 mM MgCI2, and 1.5 mM EDTA and homogenized for 5 s (Brinkman Polytron, setting 5). Samples were frozen in an ethanol/ dry ice bath and were rethawed before assay. Once thawed, samples were processed differently for [125I]iodohydroxybenzylpindolol (['25I]HYP) saturation binding than for competition binding studies and adenylate cyclase assays. For adenylate cyclase studies and isoproterenol competition binding studies, samples were thawed within 3 h of freezing. For saturation binding curves, samples were analyzed within 1 wk of processing. Freezing for up to 4 wk altered neither receptor density nor receptor affinity for antagonists. For determination of receptor density and antagonist affinity, samples were used directly after rethawing. To further reduce endogenous guanine nucleotides in competition binding studies, an additional wash was performed, followed by centrifugation at 40,000 g for 10 min. The pellet was resuspended in 10 ml of 0.9% NaCl with 20 mM Tris, 12.5 mM MgCl2, and 1.5 mM EDTA and used immediately for binding studies. The additional wash did not alter receptor density or receptor affinity for the antagonist [('I]HYP, as assessed using Scatchard transformation of saturation binding data.
For determination of adenylate cyclase activity, the samples were rethawed and centrifuged at 40,000 g for 10 min. The supernatant was discarded and the pellet resuspended in 0.5 ml of 75 mM Tris with 12.5 mM MgCl2 and 7.5 mM dithiothreitol (pH 7.4) and manually homogenized using glass/teflon homogenizer (20 (27) .
Protein concentration was determined by the method of Lowry et al. (28) , using bovine serum albumin as a standard.
[ (31) , and corrected for recovery using [3H]cAMP as the internal standard. Adenylate cyclase activity was linear with time over the 30-min incubation interval.
Catecholamine assay. Plasma epinephrine and norepinephrine were determined by radioenzymatic assay (32) .
Statistical analysis. The statistical significance of differences was determined using analysis of variance and Student's t test for paired data.
RESULTS
The binding of ['25I]HYP in the presence of the p3-receptor agonist isoproterenol resulted in shallow competition binding curves (pseudo-Hill coefficients, -0.65±0.03; range, -0.52 to -0.78), consistent with the model of receptor binding agonist with more than one affinity (Fig. 1) . Computer curve fitting of isoproterenol competition binding data was improved in all subjects by assuming a two-affinity-state model for agonist receptor interactions and the improvement from the one-affinity state was significant at the P < 0.05 level in 8 out of 10 subjects. With the addition of 0.1 mM Gpp(NH)p, the agonist competition curve Gpp(NH)p (---) is shifted to the right, is steeper, and is adequately described by a one-affinity-state model, whereas the competition curve in the absence of Gpp 1 ) and was consistent with receptor binding agonist according to the laws of simple mass action; i.e., a model with one homogeneous receptor population binding agonist with a single affinity. The rightward shift and increase in IC50 in the presence of Gpp(NH)p (from 199±9 to 532±17 nM, P < 0.01) indicates that guanine nucleotides induce a transition to the lower affinity state of the receptor. This effect of Gpp(NH)p was guanine nucleotide specific and was not observed with the addition of 0.1 mM App(NH)p, a hydrolysisresistant analog of ATP (n = 3).
In contrast to the properties of the ,3-receptor-agonist interactions, competition for ['251]HYP binding by the (3-adrenergic antagonist propranolol demonstrated competition profiles of normal steepness (pseudo-Hill coefficient not significantly different from 1). Furthermore, the addition of 0.1 mM Gpp(NH)p did not alter the competition curves for propranolol (n = 3). Thus, these data are consistent with the interpretation that the leukocyte (-receptor binds antagonist with one homogeneous affinity unaltered by guanine nucleotides.
In normal subjects, the assumption of upright posture resulted in an acute elevation of plasma norepinephrine and plasma epinephrine (Fig. 2) . Associated with the change in plasma catecholamines was an increase in the IC50 for isoproterenol competition for
[I251]HYP binding to leukocyte membranes from 199±29 to 313±43 nM, P < 0.05 (Figs. 2 and 3 ). This decrease in (3-receptor affinity for agonist (increase in IC50) was also associated with -50% reduction in the proportion of receptors binding agonist with a high affinity (%RH) upon the assumption of upright posture (Table I) . Furthermore, %RH was inversely correlated with the log plasma norepinephrine concentration (R = -0.72, P < 0.001), and with log plasma epinephrine (R = -0.50, P < 0.025). Despite the change in the proportion of (3-receptors possessing a high affinity for agonist (RH), the estimated Kd values for both the highand low-affinity states were unchanged with upright posture (Table I) .
These significant changes in receptor-agonist interactions occurring with postural change were not paralleled by alterations in receptor-antagonist interactions. Thus the Kd and Bmax for [125I]HYP binding were unchanged between samples from subjects taken when supine and upright (Kd 46±7 supine, 39±5 pM upright; Bmax 15±2 supine, 13±1 fmol/mg protein upright).
To monitor whether the washing techniques used to generate our final membrane preparation adequately removed catecholamines present in the plasma, we added norepinephrine to a final concentration of 1 ,M to samples (whole blood) and prepared control and norepinephrine-containing samples according to our typical protocol. Isoproterenol competition curves, from control and norepinephrine-added samples were indistinguishable (IC50 control, 202±60 nM; IC50 norepinephrine added, 146±39 nM), indicating that our membrane washing procedure was adequate for removal of residual catecholamines.
To assess the effect of alterations in receptor-agonist binding on (3-receptor responsiveness, we measured adenylate cyclase activity as another parameter of ,B-receptor-mediated effects. There was a significant reduction in isoproterenol-stimulated adenylate cyclase activity seen with upright posture (2.4±0. Although other hormones (e.g., renin, angiotensin) may change with catecholamines upon assumption of upright posture, the reduction in receptor affinity for agonist that we found during the infusion of norepinephrine suggests that alterations in catecholamines are either directly or indirectly related to the receptor changes. Methodologically, our study would suggest that consideration of posture (and of other factors that alter plasma catecholamines) may be important in the interpretation of studies of al-receptor responsiveness in man.
The present studies suggest that in response to acute changes in catecholamines leukocyte ,8-receptor function is primarily regulated by alterations in coupling between the receptor and the catalytic component. We have previously demonstrated (13) and recently confirmed using different techniques (36) that chronic physiological elevations in catecholamines are associated with down-regulation of lymphocyte ,8-receptor density. This mechanism must follow a longer time course and probably represents a more chronic adaptation to alterations in sympathetic activity.
Attenuation of ,B-receptor function in response to small increases in circulating catecholamines would act to dampen the effect of sudden changes in sympathetic activity. Alterations in receptor affinity for agonist with acute, physiological fluctuations in hormone levels might represent one mechanism of feedback control in the sympatho-adrenal system. 2G. A. FitzGerald, R. Feldman, and A. J. J. Wood. Unpublished observations.
